{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T20:42:48Z","timestamp":1767904968643,"version":"3.49.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"am","delay-in-days":342,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["CTN 0069"],"award-info":[{"award-number":["CTN 0069"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015615","name":"National Institute on Drug Abuse Treatment Clinical Trials Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015615","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.josat.2023.209058","type":"journal-article","created":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T22:53:14Z","timestamp":1683240794000},"page":"209058","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Perspectives on and experiences of emergency department\u2013initiated buprenorphine among clinical pharmacists: A multi-site qualitative study"],"prefix":"10.1016","volume":"155","author":[{"given":"Marissa","family":"Justen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Jennifer","family":"Edelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Chawarski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Edouard","family":"Coupet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ethan","family":"Cowan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Lyons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Owens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shara","family":"Martel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynne","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Rothman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Whiteside","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick G.","family":"O'Connor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evan","family":"Zahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gail","family":"D'Onofrio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Fiellin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn F.","family":"Hawk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.josat.2023.209058_bb0005","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.japh.2022.05.007","article-title":"Actions of the 2022 American Pharmacists Association house of delegates San Antonio, Texas March 18 \u2013 21, 2022","volume":"62","year":"2022","journal-title":"Journal of the American Pharmacists Association"},{"key":"10.1016\/j.josat.2023.209058_bb0010","series-title":"Provisional drug overdose death counts","author":"Ahmad","year":"2021"},{"issue":"17","key":"10.1016\/j.josat.2023.209058_bb0015","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.2146\/ajhp120673","article-title":"Effect of a pharmacist on timing of postintubation sedative and analgesic use in trauma resuscitations","volume":"70","author":"Amini","year":"2013","journal-title":"American Journal of Health-System Pharmacy."},{"issue":"1","key":"10.1016\/j.josat.2023.209058_bb0020","doi-asserted-by":"crossref","DOI":"10.1186\/s13722-019-0158-0","article-title":"Leveraging the role of community pharmacists in the prevention, surveillance, and treatment of opioid use disorders","volume":"14","author":"Bach","year":"2019","journal-title":"Addiction Science & Clinical Practice"},{"issue":"2","key":"10.1016\/j.josat.2023.209058_bb0025","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1177\/0897190011420160","article-title":"Pharmacist-managed antimicrobial stewardship program for patients discharged from the emergency department","volume":"25","author":"Baker","year":"2012","journal-title":"Journal of Pharmacy Practice"},{"key":"10.1016\/j.josat.2023.209058_bb0030","series-title":"Rapid assessment process: An introduction","author":"Beebe","year":"2001"},{"key":"10.1016\/j.josat.2023.209058_bb0035","series-title":"Medications for Opioid Use Disorder Save Lives","author":"National Academies of Sciences E","year":"2019"},{"issue":"1","key":"10.1016\/j.josat.2023.209058_bb0040","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13012-019-0891-5","article-title":"Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH)","volume":"14","author":"D\u2019Onofrio","year":"2019","journal-title":"Implementation Science"},{"issue":"4","key":"10.1016\/j.josat.2023.209058_bb0045","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/ajhp\/zxaa405","article-title":"Implementation of a pharmacist care manager model to expand availability of medications for opioid use disorder","volume":"78","author":"DeRonne","year":"2021","journal-title":"American Journal of Health-System Pharmacy"},{"issue":"16","key":"10.1016\/j.josat.2023.209058_bb0050","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1001\/jama.2015.3474","article-title":"Emergency department-initiated buprenorphine\/naloxone treatment for opioid dependence: A randomized clinical trial","volume":"313","author":"D'Onofrio","year":"2015","journal-title":"Journal of the American Medical Association"},{"issue":"1","key":"10.1016\/j.josat.2023.209058_bb0060","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s13181-017-0634-4","article-title":"The role of clinical pharmacists in the emergency department","volume":"14","author":"Farmer","year":"2018","journal-title":"Journal of Medical Toxicology"},{"issue":"1","key":"10.1016\/j.josat.2023.209058_bb0065","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jemermed.2015.07.040","article-title":"Pharmacist impact on ischemic stroke care in the emergency department","volume":"50","author":"Gosser","year":"2016","journal-title":"The Journal of Emergency Medicine."},{"issue":"1","key":"10.1016\/j.josat.2023.209058_bb0070","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1525822X16639015","article-title":"How many focus groups are enough? Building an evidence base for nonprobability sample sizes","volume":"29","author":"Guest","year":"2017","journal-title":"Field Methods"},{"issue":"3","key":"10.1016\/j.josat.2023.209058_bb0075","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.annemergmed.2021.04.023","article-title":"Consensus recommendations on the treatment of opioid use disorder in the emergency department","volume":"78","author":"Hawk","year":"2021","journal-title":"Annals of Emergency Medicine"},{"issue":"5","key":"10.1016\/j.josat.2023.209058_bb0080","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.4561","article-title":"Barriers and facilitators to clinician readiness to provide emergency department-initiated buprenorphine","volume":"3","author":"Hawk","year":"2020","journal-title":"JAMA Network Open."},{"issue":"1","key":"10.1016\/j.josat.2023.209058_bb0085","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1748-5908-5-82","article-title":"A critical synthesis of literature on the promoting action on research implementation in health services (PARIHS) framework","volume":"5","author":"Helfrich","year":"2010","journal-title":"Implementation Science."},{"issue":"6","key":"10.1016\/j.josat.2023.209058_bb0090","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1331\/JAPhA.2012.11136","article-title":"Pharmacy nonprescription syringe distribution and HIV\/AIDS: a review","volume":"52","author":"Janulis","year":"2012","journal-title":"J Am Pharm Assoc (2003)."},{"issue":"3","key":"10.1016\/j.josat.2023.209058_bb0095","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/M17-3107","article-title":"Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: A cohort study","volume":"169","author":"Larochelle","year":"2018","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1016\/j.josat.2023.209058_bb0100","doi-asserted-by":"crossref","first-page":"35","DOI":"10.9740\/mhc.2021.01.035","article-title":"Development and implementation of a physician-pharmacist collaborative practice model for provision and management of buprenorphine\/naloxone","volume":"11","author":"Mailloux","year":"2021","journal-title":"Mental Health Clinician"},{"issue":"2","key":"10.1016\/j.josat.2023.209058_bb0105","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002207.pub4","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","author":"Mattick","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1016\/j.josat.2023.209058_bb0110","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1016\/j.josat.2023.209058_bb0115","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.ajem.2014.07.033","article-title":"Pharmacist addition to the post-ED visit review of discharge antimicrobial regimens","volume":"32","author":"Miller","year":"2014","journal-title":"The American Journal of Emergency Medicine."},{"issue":"10","key":"10.1016\/j.josat.2023.209058_bb0120","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/j.ajem.2018.01.056","article-title":"Clinical pharmacy services in the emergency department","volume":"36","author":"Morgan","year":"2018","journal-title":"The American Journal of Emergency Medicine."},{"issue":"9","key":"10.1016\/j.josat.2023.209058_bb0125","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1097\/ACM.0000000000000388","article-title":"Standards for reporting qualitative research: A synthesis of recommendations","volume":"89","author":"O'Brien","year":"2014","journal-title":"Academic Medicine"},{"issue":"3","key":"10.1016\/j.josat.2023.209058_bb0130","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/ajhp\/zxaa378","article-title":"ASHP guidelines on emergency medicine pharmacist services","volume":"78","author":"Ortmann","year":"2020","journal-title":"American Journal of Health-System Pharmacy."},{"issue":"7","key":"10.1016\/j.josat.2023.209058_bb0135","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/ajhp\/zxab003","article-title":"Leveraging pharmacists to maintain and extend buprenorphine supply for opioid use disorder amid COVID-19 pandemic","volume":"78","author":"Peckham","year":"2021","journal-title":"American Journal of Health-System Pharmacy"},{"issue":"10","key":"10.1016\/j.josat.2023.209058_bb0140","doi-asserted-by":"crossref","first-page":"916","DOI":"10.2146\/ajhp090552","article-title":"Effect of a pharmacist-managed culture review process on antimicrobial therapy in an emergency department","volume":"68","author":"Randolph","year":"2011","journal-title":"American Journal of Health-System Pharmacy"},{"issue":"2","key":"10.1016\/j.josat.2023.209058_bb0145","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/add.13593","article-title":"Effectiveness of pharmacy-based needle\/syringe exchange programme for people who inject drugs: A systematic review and meta-analysis","volume":"112","author":"Sawangjit","year":"2017","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.josat.2023.209058_bb0055","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/acem.14369","article-title":"This is part of emergency medicine now\u201d: A qualitative assessment of emergency clinicians\u2019 facilitators of and barriers to initiating buprenorphine","volume":"29","author":"Schoenfeld","year":"2022","journal-title":"Academic Emergency Medicine"},{"issue":"3","key":"10.1016\/j.josat.2023.209058_bb0150","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jemermed.2019.12.034","article-title":"Management of opioid use disorder in the emergency department: A white paper prepared for the American Academy of Emergency Medicine","volume":"58","author":"Strayer","year":"2020","journal-title":"The Journal of Emergency Medicine"},{"issue":"6","key":"10.1016\/j.josat.2023.209058_bb0155","doi-asserted-by":"crossref","first-page":"376","DOI":"10.2146\/ajhp170294","article-title":"Establishment of a pharmacist-led service for patients at high risk for opioid overdose","volume":"75","author":"Tewell","year":"2018","journal-title":"American Journal of Health-System Pharmacy"},{"issue":"3","key":"10.1016\/j.josat.2023.209058_bb0160","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s13181-019-00712-3","article-title":"ACMT position statement: buprenorphine administration in the emergency department","volume":"15","author":"Wax","year":"2019","journal-title":"Journal of Medical Toxicology."},{"issue":"1","key":"10.1016\/j.josat.2023.209058_bb0165","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12873-021-00443-1","article-title":"A qualitative examination of the current management of opioid use disorder and barriers to prescribing buprenorphine in a Canadian emergency department","volume":"21","author":"Wiercigroch","year":"2021","journal-title":"BMC Emergency Medicine."},{"issue":"1","key":"10.1016\/j.josat.2023.209058_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00952990.2018.1546862","article-title":"Development of a cascade of care for responding to the opioid epidemic","volume":"45","author":"Williams","year":"2019","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.josat.2023.209058_bb0175","series-title":"Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence","year":"2009"},{"issue":"7","key":"10.1016\/j.josat.2023.209058_bb0180","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1111\/add.15353","article-title":"Buprenorphine physician-pharmacist collaboration in the management of patients with opioid use disorder: Results from a multisite study of the National Drug Abuse Treatment Clinical Trials Network","volume":"116","author":"Wu","year":"2021","journal-title":"Addiction"},{"key":"10.1016\/j.josat.2023.209058_bb0185","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.drugalcdep.2018.04.020","article-title":"State naloxone access laws are associated with an increase in the number of naloxone prescriptions dispensed in retail pharmacies","volume":"189","author":"Xu","year":"2018","journal-title":"Drug and Alcohol Dependence"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S294987592300108X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S294987592300108X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T01:39:41Z","timestamp":1762652381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S294987592300108X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":37,"alternative-id":["S294987592300108X"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2023.209058","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perspectives on and experiences of emergency department\u2013initiated buprenorphine among clinical pharmacists: A multi-site qualitative study","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2023.209058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"209058"}}